Latest filing published 19 Sept 2025 for Jacobio Pharmaceuticals Group Co., Ltd. - B, €960k. Read the official filing
Based on 26 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Hu Yunyan in Jacobio Pharmaceuticals Group Co., Ltd. - B. Over a trading history stretching from 21 December 2020 to 18 September 2025, the count stands at 37 filings.
On the open market, the record shows 26 purchases worth €21.0M and 8 sales worth €38.9M. The amount is not disclosed for 3 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2025: 11 purchases and 2 sales on the market.
The median purchase comes to €40k. Of 26 purchases, 26 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 26 purchases show a median change of -10.3%, with the price up in 27% of them. They describe history only and say nothing certain about the share price ahead.
On 19 September 2025 came the latest disclosure, an open-market sale for €960k in Jacobio Pharmaceuticals Group Co., Ltd. - B. The latest purchase dates back some time: it was published 411 days ago, on 5 September 2025. Typically, a trade is published a median of 3 days after it takes place. That lag is the time during which only the insider knows about the trade. Source: insider filings from HKEX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 37 declarations